China UMS
China UMS
China UMS is a payment services and intelligent business solutions provider
China UnionPay Merchant Services (UMS), founded in 2002 and headquartered in Shanghai, is a payment services and intelligent business solutions provider, established and controlled by China UnionPay. The company’s direct and indirect competitors include Ant Group, Tencent, and Ping An Pay.
- All
- News
- Analysis
- Research
Briefing Apr 23, 2022 04:46 PM
· Financials
The new generation of personal business distributed core system of postal savings bank was fully put into operation
Briefing Apr 22, 2022 05:12 PM
· Financials
Tian Huiyu, former party secretary and President of China Merchants Bank Co., Ltd., was investigated
In-depth
Briefing Apr 02, 2022 07:38 PM
· Financials
The Russian Federal reconnaissance Commission launched a criminal investigation into the Ukrainian army's attack on the oil depot in the Belgorod region
Jun 29, 2021 11:48 PM
May 03, 2021 09:18 AM
Jan 28, 2021 01:11 PM
Jan 01, 2021 12:00 AM
Briefing Nov 11, 2021 09:01 AM
· Financials
Lexin released 2021q3 financial report: revenue of 3 billion yuan and profit of 750 million yuan
Briefing Nov 08, 2021 10:47 PM
· Financials
Xiansheng yecai won PwC's strategic investment and cooperated in the field of yecai digitization
Briefing Nov 02, 2021 12:23 PM
· Financials
UnionPay business: reduce the handling fees paid by small and micro enterprises and individual industrial and commercial households
Briefing Sep 17, 2021 10:13 AM
· Financials
Xtransfer announced the completion of round D financing and will comprehensively upgrade its product and service system
In-depth
Healthcare, Financials
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Sep 13, 2021 12:19 PM
· Financials
Qiancheng capital officially announced that the phase II RMB fund with a scale of 1.3 billion was over raised
The first ESG fund evaluation system was released, and Tencent helped build a green financial system
Briefing Aug 04, 2021 08:51 PM
· Financials
Ant Group net profit decreases by 37
Healthcare, Financials
Runda Medical‘s Stock Price Dips Due to False Positive Incidents
Founded in 1999, Shanghai Runda Medical provides integrated medical laboratory service by offering a full range of IVD products. Headquartered in Shanghai, the company is one of the providers of antigen tests during the Shanghai lockdown 2022. Runda is listed on the Shanghai Stock Exchange market since 2015.
May 12, 2022 12:27 PM
Consumer Staples, Financials · Analysis
EqualOcean Presents: China Big Tech Crackdown Winners
This research report gathers all the information you need to understand the recent antitrust regulation shifts in China and analyzes ten companies that are likely to win big from them.
Jul 12, 2021 12:11 AM
Briefing Aug 02, 2021 05:01 PM
· Financials
With technological innovation, Samoye digital helped the performance of cooperative institutions soar against the trend
Briefing Aug 02, 2021 02:55 PM
· Financials
SAIC has become the intended partner for the first mass production of horizon journey 5
Briefing Jul 22, 2021 11:40 AM
· Financials
R & D "Lego building block" investment and research integrated asset management platform, and "kuantuo technology" completed a billion yuan round B financing
See more
Related Companies
EqualOcean Analysis
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.